Prescription Drug Supply Chain Pricing Transparency Act

Cost and committee reports

Official records Congress.gov attaches to H.R. 7535.

• Constitutional authority statementThe sponsor’s statement of where the Constitution gives Congress the power to pass this bill. Statement by Ms. CARAVEO, as printed in the Congressional Record (Vol. 170, No. 39, March 5, 2024, Page H822):
  Constitutional Authority--Necessary and Proper Clause (Art. I, Sec. 8, Clause 18) THE U.S. CONSTITUTION ARTICLE I. SECTION 8: POWERS OF CONGRESS CLAUSE 18 The single subject of this legislation is: To require the Comptroller General of the United States to conduct a study and submit a report on price-related compensation and payment structures in the prescription drug supply chain.
  Source: Congress.gov, Congressional Record March 5, 2024 ↗

  Evidence

  Field in the Congress.gov record

  constitutionalAuthorityStatementText

  Statement length

  384 characters

  Congress.gov bill record

  H.R. 7535, 118th Congress

  Congress.gov API record

  https://api.congress.gov/v3/bill/118/hr/7535

  Record last updated by Congress.gov

  December 5, 2025

  PORKER copy retrieved

  September 14, 2026

  Stored copy, SHA-256 of the file

  66b9bbf58df23bf23762b9c6ba0a89ef65d3369be701a96a8781100276a1bbfb

  PORKER shows the statement exactly as printed, with the page markup removed. It is the sponsor’s claim; it is not a legal finding.

Congress.gov’s record for this bill does not list a CBO cost estimate or a committee report (as of December 5, 2025). Not every bill gets one.

From the Congress.gov bill record for H.R. 7535, last updated December 5, 2025. PORKER’s copy was retrieved September 14, 2026 and is refreshed nightly. Open “Evidence” on any line for the record, field and file fingerprint.